Watch DMIIR. Know when insiders buy.
One email the day a filing lands. Free.
DMIIR
Drugs Made In America Acquisition II Corp.
No price history available
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
59
WATCH · shorts 59
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME $13MNET CASH —52W —SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$112K | $4.4M | — | — | −$173K | — | — | Aug 14 |
| Q1 2026 · Mar 31 | — | — | — | −$132K | $4.3M | — | — | −$103K | — | — | Aug 14 |
| Q4 2025 · Dec 31derived | — | — | — | −$235K | $4.3M | — | — | −$315K | — | — | Apr 15 |
| Q3 2025 · Sep 30 | — | — | — | −$156K | −$46K | — | — | −$691K | — | — | Nov 18 |
| Q2 2025 · Jun 30 | — | — | — | −$38K | −$38K | — | — | −$3K | — | — | Aug 14 |
| Q1 2025 · Mar 31 | — | — | — | −$59K | −$59K | — | — | −$10K | — | — | Aug 14 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$488K | $4.2M | — | — | −$1M | — | — | — | — |
Every number comes from Drugs Made In America Acquisition II Corp.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.